Dana Investment Advisors Inc. Has $21.41 Million Stock Position in STERIS plc $STE

Dana Investment Advisors Inc. grew its stake in STERIS plc (NYSE:STE) by 88.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 84,465 shares of the medical equipment provider’s stock after purchasing an additional 39,753 shares during the quarter. STERIS comprises approximately 0.6% of Dana Investment Advisors Inc.’s holdings, making the stock its 29th largest holding. Dana Investment Advisors Inc.’s holdings in STERIS were worth $21,413,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Board of the Pension Protection Fund acquired a new position in shares of STERIS in the 4th quarter valued at $25,000. Harbor Investment Advisory LLC lifted its stake in shares of STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 60 shares during the period. Activest Wealth Management lifted its stake in shares of STERIS by 423.8% in the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 89 shares during the period. Cloud Capital Management LLC acquired a new position in shares of STERIS in the 3rd quarter valued at $29,000. Finally, Geneos Wealth Management Inc. raised its stake in STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Activity

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the sale, the director owned 705 shares of the company’s stock, valued at $167,233.05. This trade represents a 81.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.07% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Saturday. KeyCorp dropped their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings downgraded STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, April 16th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $275.67.

STERIS Stock Performance

STE opened at $211.80 on Friday. The business’s 50-day moving average price is $219.63 and its two-hundred day moving average price is $242.91. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44. The company has a market capitalization of $20.77 billion, a price-to-earnings ratio of 26.71 and a beta of 0.95. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.75.

STERIS (NYSE:STE) last released its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a net margin of 13.18% and a return on equity of 14.15%. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business earned $2.74 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities analysts expect that STERIS plc will post 11.18 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be paid a $0.63 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio (DPR) is currently 31.78%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.